Literature DB >> 11522753

Gliotoxin stimulates the apoptosis of human and rat hepatic stellate cells and enhances the resolution of liver fibrosis in rats.

M C Wright1, R Issa, D E Smart, N Trim, G I Murray, J N Primrose, M J Arthur, J P Iredale, D A Mann.   

Abstract

BACKGROUND & AIMS: Hepatic stellate cells (HSCs) play a pivotal role in liver fibrosis and stimulating their apoptosis could be an effective treatment for liver fibrosis.
METHODS: Activated HSCs, hepatocytes, and rats with liver fibrosis were treated with gliotoxin.
RESULTS: Addition of gliotoxin to activated (alpha-smooth muscle actin positive) rat and human HSCs resulted in morphologic alterations typical of apoptosis. Within 2-3 hours of incubation, caspase 3 activity was markedly induced and caspase inhibitor 1 (Z-VAD-FMK)-sensitive oligonucleosome-length DNA fragments were detectable by gel electrophoresis of low molecular weight DNA. Apoptosis was widespread as judged by fluorescence-activated cell sorter analysis and terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate nick-end labeling staining in both rat and human HSCs at concentrations that had no effect on the viability of rat hepatocytes. Gliotoxin treatment significantly reduced the number of activated stellate cells and mean thickness of bridging fibrotic septae in livers from rats treated with carbon tetrachloride.
CONCLUSIONS: These data demonstrate proof-of-concept that by up-regulating HSC apoptosis, the extent of fibrosis can be decreased in inflammatory liver injury.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11522753     DOI: 10.1053/gast.2001.27188

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  99 in total

Review 1.  Transcriptional regulation of hepatic stellate cell activation.

Authors:  D A Mann; D E Smart
Journal:  Gut       Date:  2002-06       Impact factor: 23.059

2.  Salvia miltiorrhiza monomer IH764-3 induces hepatic stellate cell apoptosis via caspase-3 activation.

Authors:  Xiao-Lan Zhang; Li Liu; Hui-Qing Jiang
Journal:  World J Gastroenterol       Date:  2002-06       Impact factor: 5.742

Review 3.  Cirrhosis: new research provides a basis for rational and targeted treatments.

Authors:  John P Iredale
Journal:  BMJ       Date:  2003-07-19

4.  Effect of angiotensin-converting enzyme inhibition on experimental hepatic fibrogenesis.

Authors:  Cansel Türkay; Ozlem Yönem; Sema Arici; Ayhan Koyuncu; Mehmet Kanbay
Journal:  Dig Dis Sci       Date:  2007-09-01       Impact factor: 3.199

5.  Therapeutic effects of troglitazone in experimental chronic pancreatitis in mice.

Authors:  David J van Westerloo; Sandrine Florquin; Anita M de Boer; Joost Daalhuisen; Alex F de Vos; Marco J Bruno; Tom van der Poll
Journal:  Am J Pathol       Date:  2005-03       Impact factor: 4.307

6.  Nuclear factor-kappaB1 (p50) limits the inflammatory and fibrogenic responses to chronic injury.

Authors:  Fiona Oakley; Jelena Mann; Sarah Nailard; David E Smart; Narendra Mungalsingh; Christothea Constandinou; Shakir Ali; Susan J Wilson; Harry Millward-Sadler; John P Iredale; Derek A Mann
Journal:  Am J Pathol       Date:  2005-03       Impact factor: 4.307

Review 7.  Cancer-associated fibroblasts in hepatocellular carcinoma.

Authors:  Norio Kubo; Kenichiro Araki; Hiroyuki Kuwano; Ken Shirabe
Journal:  World J Gastroenterol       Date:  2016-08-14       Impact factor: 5.742

Review 8.  Treatment of hepatic fibrosis: almost there.

Authors:  Efsevia Albanis; Rifaat Safadi; Scott L Friedman
Journal:  Curr Gastroenterol Rep       Date:  2003-02

9.  Apoptosis of rat hepatic stellate cells induced by anti-focal adhesion kinase antibody.

Authors:  Xiao-Jing Liu; Li Yang; Hong-Bin Wu; Ou Qiang; Ming-Hui Huang; Ying-Ping Wang
Journal:  World J Gastroenterol       Date:  2002-08       Impact factor: 5.742

10.  Antifibrotic effects of ZK14, a novel nitric oxide-donating biphenyldicarboxylate derivative, on rat HSC-T6 cells and CCl4-induced hepatic fibrosis.

Authors:  Li Dai; Hui Ji; Xiang-wen Kong; Yi-hua Zhang
Journal:  Acta Pharmacol Sin       Date:  2009-12-07       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.